BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2926450)

  • 1. Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease.
    Mantle D; Lauffart B; Perry EK; Perry RH
    J Neurol Sci; 1989 Feb; 89(2-3):227-34. PubMed ID: 2926450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationalization of aminopeptidase activities in human skeletal muscle soluble extract.
    Lauffart B; Mantle D
    Biochim Biophys Acta; 1988 Oct; 956(3):300-6. PubMed ID: 3167075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of aminopeptidases in human kidney soluble fraction.
    Mantle D; Lauffart B; McDermott J; Gibson A
    Clin Chim Acta; 1990 Feb; 187(2):105-13. PubMed ID: 2317929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of aminopeptidase, dipeptidyl aminopeptidase and tripeptidyl aminopeptidase activities in brain tissue from normal and Alzheimer's disease cases.
    Mantle D; Perry EK
    J Neurol Sci; 1990 Aug; 98(1):13-20. PubMed ID: 2230828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional and subcellular distribution of soluble aminopeptidase in the human and the rat brain: a comparative study.
    Gil J; Larrinaga G; Meana JJ; Rodríguez-Puertas R; Irazusta J; Casis L
    Neuropeptides; 2001; 35(5-6):276-84. PubMed ID: 12030812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
    Browne P; O'Cuinn G
    Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of soluble aminopeptidases in human cerebral cortex, skeletal muscle and kidney tissues.
    Mantle D
    Clin Chim Acta; 1992 Apr; 207(1-2):107-18. PubMed ID: 1591857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
    Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
    J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of two soluble Cl(-)-activated arginyl aminopeptidases from human brain and their endopeptidase action on neuropeptides.
    McDermott JR; Mantle D; Lauffart B; Gibson AM; Biggins JA
    J Neurochem; 1988 Jan; 50(1):176-82. PubMed ID: 3275739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble and membrane-bound leucyl- and arginyl-aminopeptidase activities in subcellular fractions of young and adult rat brains.
    Ramírez M; Arechaga G; García S; Sánchez B; Lardelli P; Gandarias JM
    Rev Esp Fisiol; 1990 Dec; 46(4):393-7. PubMed ID: 2099537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of substrate requirements, kinetic properties, and competive inhibitors of the enzymes catabolizing TRH in rat brain.
    Busby WH; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 242(2):261-70. PubMed ID: 6126250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Ca(2+)-activated proteinase enzyme and endogenous inhibitor activity in brain tissue from normal and Alzheimer's disease cases.
    Mantle D; Perry EK
    J Neurol Sci; 1991 Apr; 102(2):220-4. PubMed ID: 2072120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and cytotoxicity of 2-alpha-aminoacyl prodrugs of methotrexate.
    Smal MA; Dong Z; Cheung HT; Asano Y; Escoffier L; Costello M; Tattersall MH
    Biochem Pharmacol; 1995 Feb; 49(4):567-74. PubMed ID: 7872963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of the major aminopeptidase from human skeletal muscle.
    Mantle D; Hardy MF; Lauffart B; McDermott JR; Smith AI; Pennington RJ
    Biochem J; 1983 Jun; 211(3):567-73. PubMed ID: 6882360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Gard PR; Fidalgo S; Lotter I; Richardson C; Farina N; Rusted J; Tabet N
    Exp Gerontol; 2017 Mar; 89():1-7. PubMed ID: 28069385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolyl aminopeptidase from rat brain and kidney. Action on peptides and identification as leucyl aminopeptidase.
    Turzynski A; Mentlein R
    Eur J Biochem; 1990 Jul; 190(3):509-15. PubMed ID: 2373079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of aminopeptidases in a rat saline model of volume hypertension.
    Prieto I; Martinez A; Martinez JM; Ramírez MJ; Vargas F; Alba F; Ramírez M
    Horm Metab Res; 1998 May; 30(5):246-8. PubMed ID: 9660082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of changes in hydromineral balance on rat brain aspartyl, arginyl, and alanyl aminopeptidase activities.
    Varona A; Silveira PF; Irazusta A; Valdivia A; Gil J
    Horm Metab Res; 2003 Jan; 35(1):36-42. PubMed ID: 12669269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of soluble and membrane-bound aminopeptidase activities in rat brain.
    Alba F; Arenas JC; Iribar C; Ramirez M
    Brain Res Bull; 1993; 31(3-4):393-6. PubMed ID: 8490737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of a neuropeptide-degrading aminopeptidase from human brain.
    McDermott JR; Mantle D; Lauffart B; Kidd AM
    J Neurochem; 1985 Sep; 45(3):752-9. PubMed ID: 4031861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.